SCHEMBL6068076

SCHEMBL6068076

O=[N+]([O-])c1ccc(-c2c(O)cccc2O)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.49
GPR35 Q9HC97 2/20 0.46
CSNK2A2 P19784 1/20 0.43
CSNK2B P67870 1/20 0.43
CSNK2A1 P68400 1/20 0.43
CSNK2A3 Q8NEV1 1/20 0.43
ALOX5 P09917 1/20 0.41
SMN1; SMN2 Q16637 6/20 0.40
LMNA P02545 5/20 0.40
HTT P42858 3/20 0.40
APP P05067 1/20 0.39
MAOA P21397 2/20 0.38
MAPT P10636 5/20 0.38
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 2/20 0.38
STAT3 P40763 1/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 2/20 0.37
TSHR P16473 2/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5712436 0.92 CYP2A6 (0.43) CYP2A6GPR35CSNK2A2CSNK2BCSNK2A1
SCHEMBL9777499 0.76 CYP2A6 (0.56) CYP2A6ALOX5SMN1; SMN2LMNAHTT
SCHEMBL6067937 0.76 CYP2A6 (0.67) CYP2A6ALOX5LMNAHTTAPP
SCHEMBL5704959 0.75 ALOX15 (0.49) CYP2A6ALOX5LMNAMAPTALDH1A1
SCHEMBL14664344 0.73 CYP2A6 (0.41) CYP2A6GPR35ALOX5SMN1; SMN2LMNA
SCHEMBL6280266 0.72 GPR35 (0.67) GPR35CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL6067907 0.72 ESR2 (0.43) CYP2A6ALOX5SMN1; SMN2LMNAHTT
SCHEMBL6136945 0.72 ALOX15 (0.50) CYP2A6ALOX5SMN1; SMN2LMNAAPP
SCHEMBL31707921 0.72 CYP2A6 (0.49) CYP2A6ALOX5SMN1; SMN2LMNAHTT
SCHEMBL6067980 0.71 CYP2A6 (0.53) CYP2A6ALOX5APPMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100349886-C 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2007-11-21 CN disclosed
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
CN-1633426-A 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2005-06-29 CN disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 CYP2A6 772/4885GPR35 3322/4885CSNK2A2 829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.